BDBM297351 N-(6-((3-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 19)::US10112955, Example 19

SMILES CC1CC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)cc12

InChI Key InChIKey=VQQLZYYYFZKNPK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 297351   

TargetMAP kinase-interacting serine/threonine-protein kinase 1(Human)
Effector Therapeutics

US Patent
LigandPNGBDBM297351(US10112955, Example 19 | N-(6-((3-methyl-1-oxo-2,3...)
Affinity DataIC50: 10nMAssay Description:Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Effector Therapeutics

US Patent
LigandPNGBDBM297351(US10112955, Example 19 | N-(6-((3-methyl-1-oxo-2,3...)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent